We are OneProjects
With the clinical need at the heart of what we do, we are innovators with the vision and passion to create the next generation of disruptive healthcare technologies.
OneProjects operates at the intersection of hardware, software and data science to create the future vision for healthcare and how we successfully treat patients in a new era for data driven solutions.
OneProjects operates at the intersection of hardware, software and data science to create the future vision for healthcare and how we successfully treat patients in a new era for data driven solutions.
Improving treatment of Cardiac Arrhythmias
Atrial Fibrillation
Atrial Fibrillation (AFib) is a heart rhythm disorder or irregular heartbeat that can lead to blood clots, stroke and heart failure. The disease is caused by abnormal electrical activity in the heart and patients are highly symptomatic with a dramatically increased risk to develop other diseases.
A Global Disease
Today, there are more than 38.8 million people suffering from AFib globally, with 4.5 million new cases every year. Approximately 2% of people younger than 65 have AFib, while about 9% of people aged 65 and older have it, making the disease especially critical for ageing populations.
Current Treatment
One of the principal treatments for AFib is catheter ablation, which despite technological advances is only successful in about half of the procedures performed. Many patients go on to require repeat procedures, often with a worsening condition that requires continued medical management.
From experience to evidence
OneProjects are developing VERAFEYE, a connected platform technology to revolutionise the treatment of AFib and cardiac arrhythmias.
By moving the treatment strategy from experience-based to evidence-based success, the VERAFEYE system will improve outcomes for patients, increase procedural safety and reduce cost to the healthcare system.
By moving the treatment strategy from experience-based to evidence-based success, the VERAFEYE system will improve outcomes for patients, increase procedural safety and reduce cost to the healthcare system.
Contact us for further information
Having proven the technology successfully in pre-clinical studies, the VERAFEYE technology is currently in commercial product development.
Send a Mail About OneProjects
About OneProjects
OneProjects is a privately held, venture backed medical device company based in Dublin (Ireland) and Munich (Germany) originating from Bioinnovate Ireland and spun out of Trinity College Dublin. OneProjects was founded by Fionn Lahart and Christoph Hennersperger in 2017.
Reach out
Office Dublin
OneProjects Design and Innovation Ltd.
Block C, Parkview House
Beech Hill Office Campus
Beech Hill Road
Dublin D04 K5D0
Block C, Parkview House
Beech Hill Office Campus
Beech Hill Road
Dublin D04 K5D0
Office Munich
OneProjects Design Innovation GmbH
Balanstraße 69b
81541 Munich
Balanstraße 69b
81541 Munich
Partners
